SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    R. Fernandez-Santiago, A. Iranzo, C. Gaig, M. Serradell, M. Fernandez, E. Tolosa, J. Santamaria, M. Ezquerra, Absence of LRRK2 mutations in a cohort of patients with idiopathic REM sleep behavior disorder, Neurology, 2016, 86, 11, 1072

    CrossRef

  2. 2
    Ignacio F. Mata, Marie Y. Davis, Alexis N. Lopez, Michael O. Dorschner, Erica Martinez, Dora Yearout, Brenna A. Cholerton, Shu-Ching Hu, Karen L. Edwards, Thomas D. Bird, Cyrus P. Zabetian, The discovery of LRRK2 p.R1441S, a novel mutation for Parkinson's disease, adds to the complexity of a mutational hotspot, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2016, 171, 3
  3. 3
    R. García-Ramos, E. López Valdés, L. Ballesteros, S. Jesús, P. Mir, The social impact of Parkinson's disease in Spain: Report by the Spanish Foundation for the Brain, Neurología (English Edition), 2016,

    CrossRef

  4. 4
    Johanne Hatteland Somme, Ana Molano Salazar, Amaia Gonzalez, Beatriz Tijero, Koldo Berganzo, Elena Lezcano, Manuel Fernandez Martinez, Juan Jose Zarranz, Juan Carlos Gómez-Esteban, Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene, Parkinsonism & Related Disorders, 2015, 21, 5, 494

    CrossRef

  5. 5
    José Félix Martí Massó, Juan José Zarranz, David Otaegui, Adolfo López de Munain, Neurogenetic Disorders in the Basque Population, Annals of Human Genetics, 2015, 79, 1
  6. 6
    Thomas Gasser, Usefulness of Genetic Testing in PD and PD Trials: A Balanced Review, Journal of Parkinson's Disease, 2015, 5, 2, 209

    CrossRef

  7. 7
    Andreas Puschmann, Zbigniew K. Wszolek, Movement Disorders, 2015,

    CrossRef

  8. You have free access to this content8
    Una-Marie Sheerin, Henry Houlden, Nicholas W. Wood, Advances in the Genetics of Parkinson's Disease: A Guide for the Clinician, Movement Disorders Clinical Practice, 2014, 1, 1
  9. 9
    Andrew B. West, Rita M. Cowell, João P.L. Daher, Mark S. Moehle, Kelly M. Hinkle, Heather L. Melrose, David G. Standaert, Laura A. Volpicelli-Daley, Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents, Journal of Comparative Neurology, 2014, 522, 11
  10. 10
    Donna Mae Lyn Buhat, Eng-King Tan, Genetic testing of LRRK2 in Parkinson's disease: is there a clinical role?, Parkinsonism & Related Disorders, 2014, 20, S54

    CrossRef

  11. 11
    Iakov N. Rudenko, Mark R. Cookson, Heterogeneity of Leucine-Rich Repeat Kinase 2 Mutations: Genetics, Mechanisms and Therapeutic Implications, Neurotherapeutics, 2014, 11, 4, 738

    CrossRef

  12. 12
    Taku Hatano, Manabu Funayama, Shin-ichiro Kubo, Ignacio F. Mata, Yutaka Oji, Akio Mori, Cyrus P. Zabetian, Sarah M. Waldherr, Hiroyo Yoshino, Genko Oyama, Yasushi Shimo, Ken-ichi Fujimoto, Hirokazu Oshima, Yasuto Kunii, Hirooki Yabe, Yoshikuni Mizuno, Nobutaka Hattori, Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease, Neurobiology of Aging, 2014, 35, 11, 2656.e17

    CrossRef

  13. 13
    S. N. Pchelina, A. K. Emelyanov, T. S. Usenko, Molecular basis of Parkinsons’s disease linked to LRRK2 mutations, Molecular Biology, 2014, 48, 1, 1

    CrossRef

  14. You have free access to this content14
    A. Berardelli, G. K. Wenning, A. Antonini, D. Berg, B. R. Bloem, V. Bonifati, D. Brooks, D. J. Burn, C. Colosimo, A. Fanciulli, J. Ferreira, T. Gasser, F. Grandas, P. Kanovsky, V. Kostic, J. Kulisevsky, W. Oertel, W. Poewe, J.-P. Reese, M. Relja, E. Ruzicka, A. Schrag, K. Seppi, P. Taba, M. Vidailhet, EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease, European Journal of Neurology, 2013, 20, 1
  15. 15
    R. García-Ramos, E. López Valdés, L. Ballesteros, S. Jesús, P. Mir, Informe de la Fundación del Cerebro sobre el impacto social de la enfermedad de Parkinson en España, Neurología, 2013,

    CrossRef

  16. 16
    C. Yao, W. M. Johnson, Y. Gao, W. Wang, J. Zhang, M. Deak, D. R. Alessi, X. Zhu, J. J. Mieyal, H. Roder, A. L. Wilson-Delfosse, S. G. Chen, Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity, Human Molecular Genetics, 2013, 22, 2, 328

    CrossRef

  17. 17
    Andrew B. Singleton, Matthew J. Farrer, Vincenzo Bonifati, The genetics of Parkinson's disease: Progress and therapeutic implications, Movement Disorders, 2013, 28, 1
  18. 18
    Michael C. Davis, Stephen J. Novak, Greg Hampikian, Mitochondrial DNA analysis of an immigrant basque population: Loss of diversity due to founder effects, American Journal of Physical Anthropology, 2011, 144, 4
  19. 19
    David Crosiers, Jessie Theuns, Patrick Cras, Christine Van Broeckhoven, Parkinson disease: Insights in clinical, genetic and pathological features of monogenic disease subtypes, Journal of Chemical Neuroanatomy, 2011, 42, 2, 131

    CrossRef

  20. 20
    Jaya Sanyal, Biswanath Sarkar, Sabyasachi Ojha, Tapas Kumar Banerjee, Bidhan Chandra Ray, Vadlam Raghavendra Rao, Absence of Commonly Reported Leucine-Rich Repeat Kinase 2 Mutations in Eastern Indian Parkinson's Disease Patients, Genetic Testing and Molecular Biomarkers, 2010, 14, 5, 691

    CrossRef

  21. 21
    S. Lesage, A. Brice, Bases moléculaires de la maladie de Parkinson, EMC - Neurologie, 2010, 7, 1, 1

    CrossRef

  22. 22
    S. Lesage, A. Brice, Basi molecolari del morbo di Parkinson, EMC - Neurologia, 2010, 10, 2, 1

    CrossRef

  23. 23
    Karen Nuytemans, Jessie Theuns, Marc Cruts, Christine Van Broeckhoven, Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update, Human Mutation, 2010, 31, 7
  24. 24
    Petra Yescas, Marisol López, Nancy Monroy, Marie-Catherine Boll, Mayela Rodríguez-Violante, Ulises Rodríguez, Adriana Ochoa, María Elisa Alonso, Low frequency of common LRRK2 mutations in Mexican patients with Parkinson's disease, Neuroscience Letters, 2010, 485, 2, 79

    CrossRef

  25. 25
    Javier Ruiz-Martínez, Ana Gorostidi, Berta Ibañez, Ainhoa Alzualde, David Otaegui, Fermin Moreno, Adolfo López de Munain, Alberto Bergareche, Juan Carlos Gómez-Esteban, José F. Martí Massó, Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain), Movement Disorders, 2010, 25, 14
  26. 26
    Matthew James Farrer, MOVEMENT DISORDERS 4, 2010,

    CrossRef

  27. 27
    Kristoffer Haugarvoll, Zbigniew K. Wszolek, Clinical features of LRRK2 parkinsonism, Parkinsonism & Related Disorders, 2009, 15, S205

    CrossRef

  28. 28
    A. Gorostidi, J. Ruiz-Martínez, A. Lopez de Munain, A. Alzualde, J. F. Martí Massó, LRRK2 G2019S and R1441G mutations associated with Parkinson’s disease are common in the Basque Country, but relative prevalence is determined by ethnicity, neurogenetics, 2009, 10, 2, 157

    CrossRef

  29. 29
    Coro Paisán-Ruiz, LRRK2 gene variation and its contribution to Parkinson disease, Human Mutation, 2009, 30, 8
  30. 30
    Udhaya Kumari, E. K. Tan, LRRK2 in Parkinson’s disease: genetic and clinical studies from patients, The FEBS Journal, 2009, 276, 22
  31. 31
    Ignacio F. Mata, Carlos Cosentino, Victoria Marca, Luis Torres, Pilar Mazzetti, Olimpio Ortega, Victor Raggio, Ruth Aljanati, Ricardo Buzó, Dora Yearout, Elena Dieguez, Cyrus P. Zabetian, LRRK2 mutations in patients with Parkinson's disease from Peru and Uruguay, Parkinsonism & Related Disorders, 2009, 15, 5, 370

    CrossRef

  32. 32
    Ignacio F. Mata, Carolyn M. Hutter, María C. González-Fernández, Marian M. de Pancorbo, Elena Lezcano, Cecilia Huerta, Marta Blazquez, Renee Ribacoba, Luis M. Guisasola, Carlos Salvador, Juan C. Gómez-Esteban, Juan J. Zarranz, Jon Infante, Joseph Jankovic, Hao Deng, Karen L. Edwards, Victoria Alvarez, Cyrus P. Zabetian, Lrrk2 R1441G-related Parkinson’s disease: evidence of a common founding event in the seventh century in Northern Spain, neurogenetics, 2009, 10, 4, 347

    CrossRef

  33. 33
    José-Félix Martí-Massó, Javier Ruiz-Martínez, Maria J. Bolaño, Irune Ruiz, Ana Gorostidi, Fermin Moreno, Isidre Ferrer, Adolfo López de Munain, Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2, Movement Disorders, 2009, 24, 13
  34. 34
    L. Gao, P. Gómez-Garre, F. J. Díaz-Corrales, F. Carrillo, M. Carballo, A. Palomino, J. Díaz-Martín, R. Mejías, P. J. Vime, J. López-Barneo, P. Mir, Prevalence and clinical features of LRRK2 mutations in patients with Parkinson’s disease in southern Spain, European Journal of Neurology, 2009, 16, 8
  35. 35
    John Hardy, Patrick Lewis, Tamas Revesz, Andrew Lees, Coro Paisan-Ruiz, The genetics of Parkinson's syndromes: a critical review, Current Opinion in Genetics & Development, 2009, 19, 3, 254

    CrossRef

  36. 36
    Huw R Morris, Autosomal dominant Parkinson’s disease and the route to new therapies, Expert Review of Neurotherapeutics, 2007, 7, 6, 649

    CrossRef

  37. 37
    Christine Klein, Katja Lohmann-Hedrich, Impact of recent genetic findings in Parkinson??s disease, Current Opinion in Neurology, 2007, 20, 4, 453

    CrossRef

  38. 38
    Vincenzo Bonifati, LRRK2 Low-penetrance Mutations (Gly2019Ser) and Risk Alleles (Gly2385Arg)—Linking Familial and Sporadic Parkinson’s Disease, Neurochemical Research, 2007, 32, 10, 1700

    CrossRef

  39. 39
    Carolina Perez-Pastene, Stephanie A. Cobb, Fernando Díaz-Grez, Mary M. Hulihan, Marcelo Miranda, Pablo Venegas, Osvaldo Trujillo Godoy, Jennifer M. Kachergus, Owen A. Ross, Luis Layson, Matthew J. Farrer, Juan Segura-Aguilar, Lrrk2 mutations in South America: A study of Chilean Parkinson's disease, Neuroscience Letters, 2007, 422, 3, 193

    CrossRef

  40. 40
    María C. González-Fernández, Elena Lezcano, Owen A. Ross, Juan C. Gómez-Esteban, Fernando Gómez-Busto, Fernando Velasco, Maite Alvarez-Alvarez, María B. Rodríguez-Martínez, Roberto Ciordia, Juan J. Zarranz, Matthew J. Farrer, Ignacio F. Mata, Marian M. de Pancorbo, Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain, Parkinsonism & Related Disorders, 2007, 13, 8, 509

    CrossRef

  41. 41
    Li Cao, Ting Zhang, Qin Xiao, Ying Wang, Li Bai, Guo Qiang Lu, Jian Fang Ma, Jing Zhang, Jian Qing Ding, Sheng Di Chen, The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease, Movement Disorders, 2007, 22, 16